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Enzyme aggregate 
The subcellu|ar forms of cytidyly|transferase (EC 2.7.7.15) in rat lung, rat liver, Hep G2 ceils, A ~ 9  cells and alveolar 
Type 11 cells from adult rats were separated by glycerol density centrifugation. Cytosol prepared from lung, Hep G2 
cells, A ~ 9  cells and alveolar Type il cells contained two forms of the enzyme. These species were identical to the 
L.Fonn and H-Form isolated previously from lung cytosoi by gel filtration. Liver cytosol contained only the L-Form. 
Rapid treatment of Hep G2 cells with digitonin released all of the cytoplasmic cytidyiy|transferase activity. The released 
activity was present in both H-Form and L-Form. The molecular weight of L-Form was determined from sedimentation 
coefficients and Stokes radius values to be 97690 + 10175. Thus, the L-Form appears to be a dimer of the Mr 45 000 
catalytic subunit. The f / f  * value of 1.5 indicated that the protein molecule has an axial ratio of 10, assuming a prolate 
ellipsoid shape. The estimated molecular weight of the H-Form was 284 000 ± 25 000. The H-Form was dissociated into 
L-Form by incubation of cytoso| at 370C. Triton X-100 (0.1%) and chiorpromazine (1.0 raM) also dissociated the 
H.Form into L-Form. Western blot analysis indicated that both forms contained the catalytic subunit. An increase in 
M r 45000 subunit coincided with the increase in cytidylyitransferase activity in L-Form, which resulted from the 
dissociated of H.Form. The L-Form was dependent on phospholipid for activity. The H-Form was active without |ipid. 
Phosphatidy|inositol was present in the H-Form isolated from Hep G2 ceils. The phosphatidylinositol dispersed when 
the H.Form was dissociated into L-Form. Phosphatidylinositol and phosphatidyig|ycerol cause L.Form to aggregate into 
a form similar to H-Form. Phosphatidylcho|ine/oleic acid (1:1 molar ratio) and oieic acid also aggregated the L-Form. 
Phosphatidyicholine did not produce aggregation. We conclude that the H.Form is the active form of cytidy- 
lyitransferase in cytoplasm. The H.Form appears to be a Upoprotein consisting of an apoprotein (L-Form dimer of the 
Mr 45000 snbuni0 complexed with lipids. A change in the relative distribution of H-Form and L-Form in cytosol would 
alter the cellular activity and thus may be important in the regulation of phosphatidylcholine synthesis. 
Introduction 
CTP:eholine phosphate cytidylyltransferase cata- 
lyzes the formation of CDP-choline from choline phos- 
phate and CTP. Cytidylyltransferase is a major regu- 
latory enzyme in the biosynthesis of phosphatidyl- 
choline. Although numerous studies have provided in- 
sight into the mechanisms which regulate cytidyl- 
yltransferase activity (reviewed in Refs. 1,2) a clear 
understanding of these processes remains to be achieved. 
Correspondence: P.A. Weinhold, Medical Research, VA Medical 
Center, 2215 Fuller Road, Ann Arbor, MI ,,8105, U.S.A. 
A wide variety of experimental approaches have con- 
sistently shown that increased incorporation of radio- 
labelled choline into phosphatidylcholine is correlated 
with an increase in membrane cytidylyltransferase activ- 
ity [3-23]. The increased cytidylyltransferase activity in 
isolated microsomes has been proposed to result from 
the translocation of inactive cytidylyltransferase in the 
cytosol to membranes, where it becomes active [1,24]. 
However, in many cases, the published data do not 
support translocation as the sole mechanism of activa- 
tion because the increased membrane activity was not 
matched by a decreased activity in the cytosol [14-23]. 
In other cases, the cytidylyltransferase activity increased 
in both cytosol and microsomes [14,19,20,22]. Further- 
more, hormonal modulation of phosphatidylcholine 
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synthesis during lung development caused an increase 
in cytosolic cytidylyltransferase activity without changes 
in the membrane activity [20,25,26]. Although an in- 
crease in membrane cytidylyltransferase activity ap- 
pears to be a significant component of the enzyme 
regulation, the activation or interconversion of cytosolic 
forms of cytidylyltransferase may also contribute to the 
overall control mechanisms. 
The purpose of the present study was to characterize 
in more detail the cytosolic forms of cytidylyltransferase 
and to examine the interconversion of cytosolic forms. 
These studies were facilitated by the development of a 
reproducible method to separate cytosolic forms of 
cytidylyltransferase which was applicable to relatively 
sma!! amounts of cytosolic activity. This method 
involved the separation of evtosols or postmito- 
chondrial supematants by glycerol density centrifuga- 
tion. 
Materials and Methods 
Cell culture. Hep G2 cells, a cell line derived from a 
human hepatoma, were obtained from Dr. Thomas 
Gelehrter, University of Michigan with permission from 
Dr. Barbara Knowles, the Wistar Institute, Phila- 
delphia, PA. Cells were cultured in DMEM (Duibecco's 
Modified Eagle Medium, GIBCO) containing 10% fetal 
bovine serum, and 1% (v/v) antibiotic/antimycotic 
solution (penicillin 10000 units/ml, fungizone (25 
~g/ml) and streptomycin (10 mg/ml), obtained from 
GIBCO, Grand Island, NY). A549 cells, a cell line 
derived from a human lung adenoma, were obtained 
from Dr. Jacob Finkelstein, University of Rochester 
Medical School, Rochester, NY and were cultured in 
DMEM containing 10% fetal bovine serum and 1% 
antibiotic/antimycotic solution. Alveolar Type II cells 
were isolated from rat lung exactly as described by 
Dobbs et al. [2?]. Isolated cells were cultured in DMEM 
containing 10% fetal calf serum and 1% antibiotic/ 
antimy~ti¢ solution. The cells which attached to the 
culture dish during the first 24 h were used for experi- 
ments. The cells were 8B-90% Type II cells as judged by 
Toluidine blue staining which enabled clear identifica- 
tion of lamellar body containing cells and by binding of 
Maclura pomifera lectin labelled with fluorescein (E-Y 
Laboratories, San Mateo, CA) [28]. Toluidine blue 
staining was done by adding Toluidine blue in phos. 
phate-buffered saline (0.1 ml of a 1.0% Toluidine blue 
in 1.0% sodium borate diluted in 5,0 ml of phosphate- 
buffered saline) to cell cultures. The cultures were 
incubated at room temperature for about 10 min. The 
Toluidine blue was concentrated in the lamellar bodies 
which were clearly distinguished by phase contrast mi- 
croscopy. 
Preparation of subcelhdar fractions. Rats (male, 
Sprague-Dawley; 200-225 g) were purchased from 
Charles River. The liver or hmg was perfused free from 
blood with isotonic saline, placed in a beaker on ice and 
minced with scissors. The tissue was homogenized in a 
volume of 0.15 M KCI/50 mM imidazole-HCI/1.0 mM 
EDTA (pH 7.4) (buffer A) equal to 4-times the weight 
of tissue. Homogenization was performed in a glass- 
Teflon Potter-Elvehjem homogenizer. The homogenate 
was centrifuged at 1000 x g for 10 min. The resulting 
supernatant was centrifuged at 20 000 x g for 20 rain to 
obtain a postmitochondrial supernatant. Microsomes 
were isolated from the postmitochondrial supernatant 
by centrifugation at 100000 x g for 60 rain. All steps 
were performed at 4 ° C. 
Cells were scraped from the culture dish with a 
Teflon cell scraper (Costar, Cambridge, MA) in 
Dulbecco's phosphate buffered saline (GIBCO). The 
cells were collected by centrifugation and the cell pellet 
was homogenized in buffer A by sonication (three 15 s 
bursts in an ice/water bath'). The volume of buffer A 
used for homogenization was 4-times the estimated 
volume of the cell pellet. The homogenate was centri- 
fuged at 1000 x g for 10 rain to remove any unbroken 
cells. The supernatant was placed in 1.0 ml Eppendorf 
tubes which were then placed in polycarbonate ultra- 
centrifuge tubes filled with buffer as described by 
Murthy and Bharucha [29]. Cytosolic and particulate 
fractions were prepared from the supernatant by cen- 
trifugation at 100000 x g for 60 rain in a Beckman 
L8-70m ultracentrifuge us'rig a Ti-70.1 rotor. 
Enzyme activity. Cytidylyltransferase activity was 
determined as previously described [30]. The activity in 
gradient fractions from cell cytosols was measured using 
a 300 ~tl assay volume so that 150/tl sample volumes 
could be used. Since the CDP-choline from the entire 
reaction is recovered by charcoal adsorption, this per- 
mitted us to increase the volume of fractions assayed 
without loss of sensitivity. This assay was able to detect 
activities of 0.03 nmol/min per fraction. All activities 
were determined with 500/xM phosphatidylcholine-oleic 
acid (1 : 1 molar ratio) in the assay mixture unless stated 
otherwise. Choline phosphotransferase activity was 
measured as described previously using dioleoyl- 
glycerol/phosphatidylglycerol/Tween 20 microemul- 
sion as substrate [31]. 
Density gradient centrifugations. Glycerol gradients 
(12 ml, linear 8 to 40% (v/v) in buffer A) were prepared 
with a two-chamber gradient mixer. A volume equal to 
the sample volume was removed from the top and 
replaced with sample. Centrifugation was performed in 
a SW 41 rotor at 40000 rpm for 14 h at 4°C. The 
bottom of the tube was punctured and fractions were 
collected. The pellet at the bottom of the tube was 
suspended in 0.5 ml of buffer A by repeated extrusion 
through a 100 pl Hamilton syringe. Aliquots were 
removed from each fraction for the measurement of 
cytidylyltransferase activity. Protein was determined in 
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each fraction using the Bradford assay [32]. In some 
experiments cholinephosphotransferase activity was 
determined in each fraction as a marker for micro- 
somes. 
Standard proteins were run on separate gradients 
and their positions in the gradient were located by 
protein assay. Sedimentation coefficients (s20,w) relative 
to the standard proteins were determined according to 
the method of Martin and Ames [33]. 
Gel fiTtration. Gel filtration was performed with a 
2.6 x 95 cm column of Bio-Gel A1.Sm (Bio-Rad). The 
column was equilibrated and eluted with buffer A. 
Samples (0.5 ml) were applied. The column was eluted 
at a flow rate of 8 ml/h. Calibration of the column was 
done with a gel filtration standard mixture (Bio-Rad) 
which contained thyroglobulin (R~ = 8.6 nm), gamma 
globulin (R~= 5.5 nm), ovalbumin (R~ = 2.8 nm) and 
myoglobin ( R ~  2.0 nm). Stokes radii (R,) were 
determined from linear plots of (Ka) 1/3 vs. R~. 
Cakulation of molecular weights. Molecular weights 
and frictional ratios were calculated from Stokes radius 
and sedimentation coefficients as described by Siegel 
and Monty [341. We used a value of 0.74 ml/g for the 
partial specific volume [351. We assumed a value of 0.2 
g of solvent/g of protein for the solvation factor [36]. 
Axial ratios for a prolate ellipsoid were derived from 
values given by Schachman [37]. 
Electrophoresis and electroblotting of cytidylyltrans- 
ferase. Gradient fractions were analyzed by SDS-poly- 
acrylamide electrophoresis (SDS-PAGE) [38]. Aliquots 
were precipitated with 10% trichloracetic acid. The pre- 
cipitate was dissolved in sample buffer (62.5 mM Tris/  
1% SDS/10% glycerol (pH 6.8)) and the excess tri- 
chloroacetic acid was neutralized with NH 3 (air 
delivered from a flask containing concentrated 
NH4OH). The samples were boiled for 5 min in the 
presence of 10% 2-mercaptoethanol. Separation was 
achieved on 10% gels with a 4% stacking gel. 
After SDS-PAGE, the proteins were electroblotted 
onto immobilon membranes (Millipore) using the blot- 
ting system described by Small et al. [39]. This blotting 
system allowed for the sensitive immunodetection of 
cytidylyltransferase from tissue and cell fraction. The 
more standard blotting methods did not produce 
immunopositive bands for the Mr 45000 cytidylyl- 
transferase subunit. 
lmmunodetection of Western blots. Ar~tiserum against 
purified cytidylyltransferase was raised in rabbits. 
Cytidylyltransferase was purified from rat liver as previ- 
ously described [40]. Anti-cytidylyltransferase lgG was 
isolated from the antiserum using a cytidylyltrans- 
ferase-Affiprep affinity column (Bio-Kad). Both the an- 
tiserum and the purified IgG completely titrated 
cytidylyltransferase activity in cytosol preparations from 
liver and lung. The detailed characterization of the 
antibody will be published subsequently. 
Blots were blocked at 40 °C for 2 h in 5% bovine 
serum albumin (BSA) dissolved in 25 mM Tfis/150 
mM NaCl/0.05f~ Tween 20 (TST). The blots were then 
incubated at room temperature for 2 h with a dilution 
of anti-cytidylyltransferase IgG in 1.0% BSA in T5',. 
After washing in 0.1% BSA in TST, the blot was in- 
cubated with goat roll-rabbit IgG-alkaline phosphatase 
(Sigma) at a dilution of 1:4000 in 1.0% BSA dissolved 
in TST. The blot was washed three times with TST and 
developed with 5-bromo-4-chloro-3-indolylphosphate 
(BCIP)-nitroblue tetrazolium (NBT) as described in the 
Bio-Rad instruction protocol. 
Results 
Distribution of cytidylyltransferase activity in liver and 
hmg 
The 20000 x g supernatants (postmitochondrial su- 
pernatants) from liver and lung were separated by 
glycerol density gradient centrifugation, Fig. 1A. 
Cytidylyltransferase activity in lung was separated into 
three forms; two types of soluble activity (peaks at 9.0 
ml and at 5.0-6.5 ml) and microsomal activity (pelleted 
at the bottom of the tube, indicated as 0). Over 98% of 
the activity of choline phosphotransferase, a micro- 
somal enzyme, was recovered at the bottom of the 
gradient (data not shown). The separation of lung cyto- 
sol (100000 × g supernatant) by glycerol density cen- 
trifugation resulted in the appearance of two peaks of 
activity within the gradient, Fig. lB. There was no 
activity at the bottom of the tube when cytosol was 
used. This comparison demonstrated that the cytidylyl- 
transferase activity at the bottom of the post-mitochon- 
drial gradients was microsomal-bound enzyme. 
We reported previously that adult rat lung contains a 
high-Mr (H-Form) and a lower-Mr (L-Form) species of 
cytidylyltransferase in cytosol [41,43]. These forms were 
classified according to their elution from Bio-Gel AS.0m 
gel-filtration columns. In order to establish that the 
forms isolated by glycerol density centrifugation were 
the same as those isolated by gel filtration, we applied 
H and L Forms isolated by gel filtration onto glycerol 
density gradients. The H-Form activity peaked at 6.2 ml 
and L-Form peaked at 9.2 ml. In addition, fractions 
between 5.5 and 6.5 ml and 8.6 and 9.8 ml from glycerol 
gradients of lung cytosol samples were combined and 
analyzed by gel filtration. The 8.6-9.8 ml pool eluted as 
L-Form and the 5.5-6.5 ml pool eluted as H-Form. 
Thus, the forms isolated by glycerol density centrifuga- 
tion were identical to those previously isolated by gel 
filtration. 
Postmitochondrial supernatant and cytosol from liver 
contained only L-Form cytidylyltransferase, Fig. 1A 
and B. Although a small amount of high-molecular- 
weight form of cytidylyltransferase has been reported to 
be present in liver cytosol preparations when separated 
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by gel-filtration chromatography [42,431, we found no 
evidence for a highoM r form in the glycerol gradients. 
The above e~periments used subcellular preparations 
isolated from homogenates prepared in buffer A. The 
homogenization of lung in different buffers did not 
significantly alter the gradient profiles of cytidylyl- 
transferase in cytosolic preparations. Gradient profiles 
of cytosol prepared from lung by homogenization in 50 
mM Tris/0.25 M sucrose/2 mM EDTA were similar to 
those in Fig. 1 (data not shown). Lung was also ho- 
mogenized in 50 mM Tris buffer containing either no 
KCi, 50 mM KCI or 150 mM KCI. Gradient profiles of 
the cytosolic fractions were similar to those in Fig. 1 
(data not shown). The amount of total activity was 
much lower in the cytosol from the homogenates pre- 
pared without KCI. The total activity increased in the 
50 mM KCI cytosol and was the highest in the 150 mM 
KC! cytosol. However, the relative amounts of the two 
forms of cytidylyltransferase wa: similar in all three 
cytosolic preparation. The use of NaCI instead of KCI 
did not change the results. 
The higher-molecular-weight form is prominent in 
cytosols prepared from lung. Lung contains pulmonary 
surfactant, a lipoprotein complex which includes rela- 
tively high amounts of phosphatidylcholine and phos- 
phatidylglycero|. We examined the possibility that the 
higher-molecular-weight form was an artifact due to 
binding of cytosolic cytidylyltransferase to surfactant 
components derived from alveolar surfactant during 
homogenization. Extensive lavage of adult rat lung (ten 
times with 10 mi of isotonic saline) was performed prior 
to homogenization in buffer A. This did not ch~ige the 
gradient profile of cytidylyttransferase activity in the 
cytosolic preparation (data not shown). 
Distribution of cyti@iyltransferase activity in cells 
Isolated alveolar Type It cells, Hep (32 cells and 
A549 cells contained both cytosolic forms of cytidy- 
iyltransferase, Fig. I C. The high-molecular=weight form 
predominated, particularly in A549 cells and alveolar 
Type II cells. The total activity in homogenates of A549 
cells and Hep (32 cells was 9.9 + 1.6 nmol/min per mg 
DNA (n = 6) and 12.9 =l: 1.9 nmol/min per mg DNA 
(n = 4), respectively. Cytosols from A549 cells con- 
tained 43 ± 3~ of the total activity. Cytosols from Hep 
(32 cells contained 56 + 0.5~ of the total activity. In 
Hep (32 and A549 cell lines more than 90~ of the 
cytidylyltransferase activity appeared to be either asso- 
ciated with microsomal membranes or in a high-molecu- 
lar-weight complex in cytosol fractions. 
Distribution of cyti@lyltransferase activity released from 
cells by digitonin 
Mackall et al. [49] developed a procedure for the 
rapid release of cytoplasmic enzymes from cultured cells 
with minimal organelle disruption. This method has 
been used to demonstrate translocation of cytidylyl- 
transferase in HeLa cells [7] and in Chinese hamster 
ovary cells [10]. We applied this method to Hep (32 cells 
and examined the soluble forms of cytidylyltransferase 
released. Cells were harvested from 100 mm dishes by 
gentle scraping and collected by centrifugation at 800 × 
g. A 1 rain exposure of the cell pellet to 0.8 mg/ml 
digitonin in buffer A followed by centrifugation at 
9000 × g for 10 rain released 10.5 + 0.03 nmol/min per 
dish (n = 3) of cytidylyltransferase activity. The pellet 
was processed further by sonication in buffer A. The 
sonicate was centrifuged sequentially at 2000 rpm for 10 
rain to give a low-speed pellet, 10 000 × g for 20 min to 
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Fig. 2. Glycerol density gradient analysis of  cytidylyltransterase activ- 
ity released by digitonin treatment of  Hep G2 cells. The profile is the 
average of three independe~t experiments. Each experiment used the 
combined cells from five dishes (100 ram) of Hep G2 cells. Cells were 
plated at 2.10 ~ cells per dish and cultivated 4 days. The error bars 
represent the standard deviations for ~he three experiments. 
give a 10000 X g pellet and 100000 x g for 60 rain to 
give a microsomal pellet and a supernatant. The sum of 
the activity in the three particulate pellets (low-speed, 
10000 × g and 100000 x g) was 3.8 =t= 0.03 nmol /min  
per dish. There was only 0.21 =1= 0.05 nmol/min per dish 
in the high-speed supematant. Thus, the digitonin treat- 
ment released essentially all of the cytoplasmic enzyme 
activity. Cholinephosphotransferase activity was also 
determined as a marker for endoplasmic reticulum 
membranes. Less than 570 of the total cholinephospho- 
transferase activity was released by digitonin treatment. 
Gradient density centrifugation of the digitonin super- 
natant showed that both forms of cytidylyltransferase 
were present (Fig. 2). In addition, there was some 
activity at the bottom of the gradient tube (fraction 0 in 
Fig. 2). This activity accounted for about 2070 of the 
total activity released by digitonin. All of the choline- 
phosphotransferase activity in the digitonin supernatant 
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Fig. 3. The determination of  sedimentat ion coefficients for the 
cytidylyltransferase forms separated by glycerol density centrifuga- 
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the gradient. 
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pelleted material is probably a small amount of mem- 
brane fragments. The results described above were ob- 
tained from three separate expefiments~ It is noteworthy 
that 737o of the total cytidylyltransferase was released 
by digitonin compared ~(> 56~ of the tot:~ ~:~c~ivi~v 
recovered in cytosols prepared by differential centrff: 
ugation of cell sonicates. The lower recovery could be 
due to binding of soluble cytidylyltransferase to mem- 
branes after the cells were broken. Since digitonin treat- 
ment releases soluble enzyme without extensive damage 
to intraceUular membranes, enzyme binding to mem- 
brane fragments would be less likely. 
Calibration of glycerol gradients and determination of 
molecular weights 
Protein standards were separated on the glycerol 
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FiB, 5. The time dependency of the dissociation of H-Form to 
L.Form, The relative amounts of H.Form and L-Form were 
determined at e~h time point by fractionation of ¢ytosols by glycerol 
density centdfugation. Incubation wa~ perfo~ed at 37°C for the 
d~ignated time and then rapidly cooled in an ice.bath. 
the location on the gradients is shown in Fig. 3. Three 
independent analyses of the separation of the standards 
were performed. The relative positions of the standards 
were similar for the three experiments. The sedimenta- 
tion coefficients for the two forms of cytidylyl- 
transferase in lung eytosol were determined to be 4.8 =[: 
0.5 S and 13.4 :t: 1.2 S (n - 9). A Stokes radius of 48 A 
was determined for the 4.8 S form by gel filtration 
chromatography. The molecular weight of the 4.8 S 
form was calculated to be 97690 :t: 10175. The f / f '  
was 1.5. Assuming a prolate ellipsoid, an axial ratio of 
10 was obtained from tables given in g e l  37. Thus, the 
4.8 A form EL-Form) appears to be an elongated mole- 
cule. An approximate molecular weight of 284000 :t: 
25 000 was obtained for the H-Form by glycerol gradi- 
ent centrifugation using a plot of molecular weight of 
standard proteins versus the migration distance in the 
8tadient~ The molecular weight of the L-Form, esti- 
mated similarly by density gradient centrifugation, was 
90000, which is similar to the calculated molecular 
wei t. 
Con~rsion o/ H, Form to L.Form 
A 15 rain incubation at 37 °C of cytosol preparations 
from lung, Hep G2 cells and alveolar Type II cells 
dissociated the H-Form into L-Form (Fig. 4). The dis- 
sociation was time dependent (Fig. 5). Approximately 
Fit. 6, Western blot anal)mis of 81yc~rol wadient fractions from lung 
eytosol kept on ice (A), in~:ubated at 37QC for 15 rain (B) and from 
liver ~to~)i kept at 4°C (C). A 50 F! sample from fractions at the 
various gradiqmt volum~ were mixed with 50 F! of SD$ sample buffer 
and separated by gDS-PAGE on a 10~ gel. The amount of cytidylyl- 
tramferase activity (CT activity) in the 50/tl aliquot is represented by 
the bar graph. The CT activity is plotted as nmol/min. 
half of the H-Fo~m dissociated to L-Form in 4 rain. The 
sum of the activity in all forms decreased by less than 
10% during this 4 min incubation, indicating that the 
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Fig. 7. The lipid requirement for cytidylyltransferase activity in the H-Form and L-Form. Activity in the fraction was determined either without 
lipid added to the assay or with 500 ~M phosphatidylcholine-oleic acid vesicles (1 : 1 molar ratio). The vesicles were prepared by sonication and the 
concentration refers to the amount of phosphatidylcholine. (A) Lung cytosol at 4°C;  (B) lung cytosol incubated at 37°C for 15 rain before 
application to the gradient. 
decrease in activity in the H-Form was not due to an 
inactivation of enzyme. 
Western blot analysis of fractions from the gradients 
indicated that the shift in the sedimentation pattern of 
the enzyme activity was associated with a corresponding 
shift in the M r 45000 subunit of cytidylyltransferase 
(Fig. 6). The M r 45 000 subunit of cytidylyltransferase 
also coincided with the enzyme activity in the gradient 
from liver cytosol, (Fig. 6). 
The H-Form of cytidylyliransferase was partially ac- 
tive without the addition of lipid cofactors to the assay 
(Fig. 7A). The L-Form was essentially inactive in the 
absence of lipid cofactors. The L-Form released from 
the H-Form complex showed the same lipid dependence 
(Fig. 7B). The temperature and time dependency of the 
dissociation suggested that it may involve some type of 
enzymatic reaction. Proteinase activity appeared not to 
be involved because the addition of a mixture of pro- 
teinase inhibitors (2 mM DMSF, 5/Lg/ml pepstatin, 0.1 
igg/ml tosyl chloromethylketone, 5/.tg/ml antipain) did 
not prevent the dissociation. It appeared unlikeb that 
protein phosphatase activity was involved, since the 
addition of 150 mM potassium fluoride did not prevent 
the dissociation. The addition of 3 mM ATP/10 mM 
Mg 2+ to the cytosol also did not alter the dissociation. 
Quinicrine, a phospholipase inhibitor, added at a final 
concentration of 4.0 mM had no effect on the dissocia- 
tion. Since 2 mM EDTA was present in the cytosol 
preparation, it would seem unlikely that C a  2+ requiring 
phospholipases would be active. Nevertheless, we added 
10 mM Ca 2+ to the cytosol incubations and found this 
did not alter the dissociation. The addition of 10 mM 
iodoacetamide or 20 mM dithiothreitol did not prevent 
the dissociation. This suggests that exposed sulfhydryl 
groups are not involved. Since fatty acids have been 
demonstrated to promote the binding of cytidylyl- 
transferase to microsomal membranes [24], we examined 
the effect of 200/~M oleic acid and 29~ bovine serum 
albumin (fatty acid free). Neither addition altered the 
conversion of H-Form to L-Form. 
The H-Form complex was isolated from the gradient 
peak by ammonium sulfate precipitation. AIi of the 
activity was recovered in the precipitate at 20 to 40% 
saturation of ammonium sulfate. The H-Form isolaled 
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Fig. 8. Glycerol gradient analysis of H-Form isolated by ammonium 
sulfate preci#tation of gradient fractions. The isolated H-Form was 







5,0 . . . .  w . . . .  , . . . .  • . . . .  • . . . .  l . . . .  , . . . .  • . . . .  , . . . .  , . . . .  • . . . .  i . . .  ; l W - , ,  r 
A EFFECT OF TRITON XlO0 . , / ~  
0 - - 0  J.UNG CYTOSOL 
0 - - 0  LUNG CYTOSOL + TRITON 
? 
0.0 
" , ,  :r e o lo 11 12 
VOLUME (ml) 
i 
B EFFECT OF CHLORPROMAZIN[ 
0 ~ 0  LUNG CYTOSOL 
/ 9  ,5 1 = - - =  CYTOSOL+ CHLORPROMAZINE ] ~  
I t  
°+  1 
GO + - - °  
0 t 2 3 4 s s 7 8 9 10 11 12 
VOLUME (ml) 
Fig. 9. The dissociation of H-Form cytidylyltransferase to L-Form 
cytidylyltransferase, Triton X-100 (0,19~) or chlorpromazin¢ (1 raM) 
was added to lun8 cytosol and then kept on ice for 30 mJn before 
application to the gradients, 
8radient centrifugation, (Fig, 8A), Furthermore, the 
H-Form complex was separated from the bulk of the 
protein, This s ~ e s t s  that the H, Form complex is a 
minor protein component in the crude preparation. 
Incubation of the isolated H-Form at 37°C for 15 min 
resulted in a dissociation of the complex into L-Form 
cytidylyltransferase (Fig. 8B). Some of the activity ap- 
peared to form larger aggregates. The protein profile 
was not altered by the 37°C incubation. 
The addition of Triton X-100 (0.19~ final concentra- 
tion) to lung cytosol at 4°C dissociated the H-Form to 
L-Form (Fig. 9A). A similar result was obtained with 
cytosol from Hap G2 cells (data not shown). The 
addition of chlorpromazine (1.0 mM) to lung cytosol at 
4°C also dissociated the H-Form into L-Form (Fig. 
9B), The dissociation was accompanied by an apparent 
inhibition of activity when assayed without fipid, (Fig. 
10). There was no inhibition when fipid was added to 
the assay. This result is consistent with a chlorproma- 
zinc-induced dissociation of an active H-Form into 
inactive L-Form. The concentration of chlorpromazine 
required in these experiments is substantially higher 
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Fig. 10. The effect of chlorpl+omm~ine on cytidylyltransferase activity 
in lung cytosoL The cymsol.chlorpromazine mixtures were pr~m- 
cubated on ice for 30 rain, Aliquots were removed and assayed either 
without lipid (O) or with 500 p M phosphatidylcholine-oleic acid 
vesicles (1 : l molar ratio) (o), 
poration into phosphatidylcholine and cytidylyl- 
transferase activity in HeLa cells [48]. Thus, it is uncer- 
tain whether the in vitro dissociation of H-Form can 
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Fig. 11. The effect of chlorpromazine on the distribution of cytidy- 
iyltransferase activity and [3H]inositol in Hap (32 cytosol. Hap G2 
cells were incubated with [3H]inositol for 24 h. Cytoso] was prepared 
and separated by glycerol density centrifugation. (A) The distribution 
of cytidylyltransferase activity in samples incubated at 4 ° C  with 1.0 
mM chlorpromazine (®) compared to untreated controls (o). (B) The 
distribution of [3H]inositol in samples incubated at 4 ° C  with 1.0 mM 
chlorpromazine (O) compared to untreated controls (o). 
Lipid involvement in H-Form aggregate 
Evidence for the involvement of phospholipid in the 
H-Form aggregate was obtained from experiments with 
cultured Hep G2 cells. Hep G2 cells were cultured for 
24 h in the prese~ce of 2 #Ci /ml  [~H]inositol. The cells 
were collected and homogenized. Cytosol (2.0 ml) was 
prepared. Chlorpromazine was added to 1.0 ml to give a 
final concentration of 1.0 raM. The two samples (con- 
trol and chlorpromazine) were separated by density 
gradient centrifugation. The distribution of cytidylyl- 
transferase activity in the gradient is shown in Fig. l lA .  
Chlorpromazine caused a dissociation of the H-Form to 
yield more L-Form enzyme. The distribution of radioac- 
tivity in the gradient is shown in Fig. l lB. The peak of 
radioactivity between 4.0 and 7.0 ml in the gradient was 
extracted with chloroform/methanol (2:1). After the 
addition of water and separation of phases by centrif- 
307 
ugation, all of the radioactivity was recovered in the 
chloroform phase. Thin-layer chromatography of the 
chloroform-soluble lipid indicated that the radioactivity 
was in phosphatidyl/nositol. Thus, phosphatidylinositol 
was present in the H-Form peak from the gradient. 
Chlorpromazine apparently dissociated the aggregate 
releasing the dimer L-Form of cytidylyltransferase and 
the phosphatidylinositol. The dissociated phosphatidyl- 
inositol was recovered at the bottom of the gradient. 
Thin-layer chromatography of the lipid extract of the 
pellet at the bottom of the gradient indicated that the 
radioactivity was in phosphatidylinositol. The radioac- 
tivity at the top of the gradient was water-soluble and 
presumed to be [ 3 H]inositol. 
Further evidence for the involvement of lipid was 
obtained by in vitro studies with lur~g cytosol. The 
results of these experiments are shown in Fig. 12. The 
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Fig. 12. The aggregation of L-Form by lipids. Lung cytosol was incubated at 37 °C for 15 rain. The appropriate lipid was added after the incubated 
cytosol had been cooled on ice. The lipid-cytosol mixture was kept on ice for an additional 30 ndn and then applied to a glycerol gradient. The 
fipids were added from a 0.5 mM stock which was prepared in buffer A by sonication. (A) o,  37°C cytosol; B, 37°C cytosol+50 pM 
phosphatidylglycerol. (B) o,  37 °C cytosol; m, 37 °C cytosol + 50 #M phosphatidylinositol; A, [3H]phosphatidylinositol. (C) o,  37 °C cytosol; ®, 
37 °C  cytosol + 50/~M phosphatidylchofine. (D) o,  37 °C cytosol; e ,  37 °C  cytosol + 100 #M oleic, added as phosphatidylcholine/oleic acid (1:1 
molar ratio). (E) O, 37°C cytosol; o, 37°C cytosoi+50 laM oleic acid. (F) O, 50 #M [3H]oleic acid added f~ ~..~Iu~oi; o,  100 pM [3H]oleic acid 
added to cytosol as phosphatidylcholine/oleic acid mixture; ,., [14C]phosphatidylcholine added to cytosol as phosphatidylcholine/oleic acid 
mixture; B, phosphatidylcholine/[ 3H]oleic acid mixture applied without cytosol (refer to right side of figure). 
~ 8  
basic protocol involved the dissociation of the H-Form 
to L-Form by incubation of cytosol at 37 o C for 15 min. 
A 1.0 ml portion was then mixed with lipid and applied 
to a gradient. Another 1.0 ml portion was applied 
directly to the gradient as a control. Phosphatidyl- 
glycerol (panel A) and phosphatidylinositol (panel B) 
caused formation of a high molecular weight aggregate 
which mov~>;I in the gradient to a position similar to the 
H.Form aggregate. The position of phosphatidylinositol 
in the gradient was monitored by including [~H]phos- 
phatidylinositol in the mixture. Most of the phospha- 
tidylinositol moved with the enzyme aggregate. The 
concentrations (50 p M) of phosphatidylglycerol and 
phosphatidyUnositol is sufficient to stimulate enzyme 
activity in cytosol preparations. Phosphatidylcholine 
(panel C) did not cause aggregation. However, phospha- 
tidylcholine-oleic acid (1:1 molar ratio) formed a high 
molecular weight aggregate, panel D. Oleic acid also 
formed some aggregate but was less effective than the 
phosphatidylcholine/oleic acid mixtures, panel E. Oleic 
acid was added at 50/~M because this concentration 
produced stimulation of cytosol activity. However, max- 
imal activity cannot be obtained with oleic acid because 
concentrations above 80 tzM tend to cause inhibition of 
activity. Panel F shows the distribution of oleic acid 
alone or as a part of phosphatidylcholine/oleic acid 
mixture. The major portion of the oleic acid in both 
cases did not move in the gradient with the high-molec- 
ular-weight aggregate. A small and similar amount of 
oleic acid was present in the aggregate region of both 
gradients. The phosphatidylcholine part of the phospha- 
tidyicholine/oleic acid mixture formed two peaks, one 
of which was in the aggregate region. All of the above 
results were obtained by adding the lipids to cytosol. 
When phosphatidylcholine/oleic acid mixture was ap- 
plied to a gradient without cytosoi, the lipid mixture 
remained at the top of the gradient. These results indi. 
cate that the phosphatidycholin¢/oleic acid vesicles did 
not remain intact in cytosol. Instead, it appears that 
o1¢i¢ acid was removed from the vesicle, probably by 
binding to cytosolic proteins. These results suggest that 
the formation of cytidylyltransferase aggregates is not 
simply due to binding of cytidylyltransferase to the 
original phosphatidylcholine-oleic acid vesicles. 
Discussion 
The lowest-molecular-weight species of cytidy- 
lyltransferase which retains enzyme activity appears to 
be a dimer of the M, 45 000 catalytic subunit. This form 
(L-Form) is essentially inactive in the absence of lipids 
in the assay. The molecular weight of the L-Form was 
previously estimated by gel-f'dtration chromatography 
to be 170000-200000 [41,42,44]. It is now apparent that 
this molecular weight was too high. The L-Form of 
cytidylyltransferase is not a globular protein, but rather 
it appears to be an elongated molecular with an axial 
ratio of 10. Thus, gel-filtration would give an apparent 
higher molecular weight based on the molecular weights 
of standard globular proteins. The relative molecular 
weight of the H-Form has been estimated by gel filtra- 
tion chromatography to be over 1.10 o [42,50]. The 
molecular weight estimated by density gradient centrif- 
ugation was on the order of 250000-300000. This dis- 
crepancy could also be due to an elongated physical 
shape of the aggregate. Alternatively, it may be caused 
by a high lipid content which could increase the relative 
buoyancy of the complex on density gradients. Recent 
studies using cross-linking reagents provided evidence 
that purified cytidylyltransferase exists as a dimer of M r, 
45000 subunits [53]. 
We reported previously that the high molecular 
weight form (H-Form) was the predominant form in 
100000 x g supernatant from adult rat lung [41,43]. The 
results in this paper verified this finding using a differ- 
ent method for fractionation of the cytosol. Since 
cytidylyltransferase is known to bind to lipid vesicles 
[44,51] and microsomal membranes in vitro [24,52] it is 
possible that the high-molecular-weight aggregate was 
formed during or after homogenization. The results 
from a variety of experimental approaches indicated 
that the H-Form in cell cytoplasm was not an artifact 
produced by homogenization. This conclusion is based 
on the fact that neither homogenization of lung in 
several different buffers or removal of pulmonary 
surfactant prior to homogenization changed the distri- 
bution in the cytosol. Furthermore, H-Form was pre- 
sent in cultured Hep G2 cells and A549 cells. These are 
established cells lines derived from tumors of different 
tissue origin. Alveolar type 11 cells, isolated from rat 
lung, also contained the H-Form as the predominant 
cytosolic form. Finally, permeabilization of Hep G2 
cells with digitonin resulted in a rapid release of cytidyl- 
yltransferase. The released activity consisted of both H 
and L forms of cytidylyltransferase. Thus, the H-Form 
appears to be a physiologically relevant form of cytidy- 
lyltransferase which may, in some cells, be the predomi- 
nant cytosolic form. 
The H-Form appears to be a lipoprotein complex of 
the L-Form. In this context, the L-Form would be the 
apoprotein part of the lipoprotein. The H-Form was 
dissociated by Triton X-100 and by chloropromazine. 
Triton X-100, is widely used to dissociate phospho- 
lipid-protein complexes in membranes. Chlorpromazine 
also has been reported to dissociate complexes of anionic 
phospholipid and protein in membranes [45-47]. The 
simultaneous dissociation of [3H]phosphatidylinositol 
and L-Form from the H-Form in Hep G2 cells provided 
evidence that phosphatidylinositol may be involved in 
the H-Form complex in these cells. The ability of phos- 
phatidylinositol to form a high-molecular-weight com- 
plex from L-Form in lung cytosolic preparations pro- 
vided additional evidence. However, the formation of 
high-molecular-weight complexes with phosphatidyl- 
glycerol, phosphatidylcholine/oleic acid mixtures and 
oleic acid indicated that phosphatidylinositol was not 
specific. It seems likely that the addition of the ap- 
propriate lipid nfi×ture converts the inactive apoprotein 
(L-Form) to an active lipoprotein (H-Form). All of the 
lipids or lipid mixtures which promoted the aggregation 
also stimulate cytidylyltransferase activity. Since the 
H-Form is active without the addition of lipid to the 
assay, the amount of H-Form in cytosols may be an 
indication of the existence of active cytidylyltransferase 
in the cytosolic pool. The exact composition of the 
aggregate, stoichiometric relationships between L-Form 
and lipid, and orientation of the enzyme in the lipid 
aggregate is unknown. Since there appeared to be slight 
differences in the sedimentation position in the gradient 
when different lipids were used and in different cell 
types, the actual size of the aggregate may depend upon 
the lipid composition and/or  the relative amounts of 
L-Form and lipid. Further clarification will require a 
more purified preparation of the H-Form lipoprotein. 
It is now apparent that cells can contain cytidylyl- 
transferase in three physical forms: membrane-bound, 
H-Form aggregate in cytoplasm and a dimer L-Form in 
cytoplasm. The distribution of the total activity among 
these forms may have regulatory significance. Both the 
membrane-bound form a~d the H-Form complex ar~ 
active as isolated from cells. The L-Form is essentially 
inactive. Assuming this ~ame property exists in the cell, 
the conversion of L-Form to either the H-Form aggre- 
gate or to membrane-bound form would result in an 
increase in cytidylyltransferase activity. Conversely, dis- 
sociation of either membrane-bound or H-Form aggre- 
gate to L-Form would lead to a decrease in cytidylyl- 
transferase activity. 
The most prevalent model for the regulation of 
cytidylyltransferase involves a translocation of cytosolic 
enzyme to membrane-bound enzyme [1]. Although 
translocation clearly occurs under some situations in the 
regulation> of cytidylyltransferase activity, interconvgr- 
sions of cytosolic forms also may be a significant regu- 
latory event. Indeed, the conversion of L-Form to H- 
Form in addition to translocation to membrane-bound 
forms may explain the results in the literature which can 
not be explained by translocation alone. In any case, a 
decision concerning the regulatory mechanism requires 
an assessment of both the distribution of cytidylyl- 
transferase in cytosolic forms and in membranes. Fur- 
ther studies are in progress to determine the relative 
importance of the aggregate form of cytidylyltransferase 
and to define the dynamics of interconversions between 
the subcellular forms. 
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